Patents by Inventor Bernard Klonjkowski

Bernard Klonjkowski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Recombinant adenoviral vectors and applications thereof
    Patent number: 8119396
    Abstract: Recombinant adenoviruses or pseudoviruses having a deletion of all or part of the region of the adenovirus genome corresponding to nucleotides 311 to 499 in canine adenovirus type 2 (GeneBank J04368). Therapeutic methods of using the recombinant adenovirus or pseudovirus.
    Type: Grant
    Filed: October 8, 2003
    Date of Patent: February 21, 2012
    Assignees: Institut National de la Recherche Agronomique (INRA), Ecole Nationale Veterinaire d'Alfort
    Inventors: Marc Eloit, Bernard Klonjkowski
  • Recombinant adenoviral vectors and applications thereof
    Publication number: 20060233756
    Abstract: The invention relates to novel recombinant adenoviruses which can be obtained from a replicating adenovirus by deleting all or part of the region of the genome of said replicating adenovirus corresponding to that located in the genome of canine adenovirus type 2 (GenBank J04368) between positions 311 and 499, the aforementioned deletion comprising all or part of the region of the genome of the original replicating adenovirus corresponding to that located between positions 311 and 401 in the genome of canine adenovirus type 2. The invention also relates to the uses of said adenoviruses, particularly for therapeutic purposes.
    Type: Application
    Filed: October 8, 2003
    Publication date: October 19, 2006
    Inventors: Marc Eloit, Bernard Klonjkowski
  • Adenoviral vectors of canine origin
    Patent number: 6294377
    Abstract: The present invention resides in use of a recombinant adenovirus of animal origin containing a heterologous DNA sequence for the preparation of a pharmaceutical composition intended for the therapeutic and/or surgical treatment of the human body.
    Type: Grant
    Filed: November 17, 1995
    Date of Patent: September 25, 2001
    Assignee: Rhone-Poulenc Rorer SA
    Inventors: Hedi Haddada, Bernard Klonjkowski, Michel Perricaudet, Emmanuelle Vigne
  • Adenoviral vectors of canine origin
    Patent number: 5891715
    Abstract: The present invention resides in use of a recombinant adenovirus of animal origin containing a heterologous DNA sequence for the preparation of a pharmaceutical composition intended for the therapeutic and/or surgical treatment of the human body.
    Type: Grant
    Filed: November 17, 1995
    Date of Patent: April 6, 1999
    Assignee: Rhone-Poulenc Rorer SA
    Inventors: Hedi Haddada, Bernard Klonjkowski, Michel Perricaudet, Emmanuelle Vigne